Smooth muscle cell (SMC) rarefaction is involved in the development of several vascular pathologies. We suggest that the plasminogen activation system is a potential extracellular signal that can induce pericellular proteolysis and apoptosis of vascular SMCs. Using primary cultures of arterial SMCs, we show that plasmin generated from plasminogen on the cell surface induces cell retraction and fibronectin fragmentation, leading to detachment and morphological/biochemical changes characteristic of apoptosis (also called anoikis). The generation of cell-bound plasmin mediated by tissue-type plasminogen activator (t-PA), constitutively expressed by VSMCs, requires binding of plasminogen to the cell surface and is inhibited by ε-aminocaproic acid (IC 50 =0.9±0.2 mM), a competitor of plasminogen binding to membrane glycoproteins. Conversely, addition of α 2 -antiplasmin, which blocks free plasmin in the cell supernatant, could not fully prevent anoikis. Finally, an MMP inhibitor failed to prevent VSMC anoikis, arguing for a direct involvement of plasmin in this phenomenon. Indeed, similar changes are induced by plasmin directly added to VSMCs or to arterial rings, ex-vivo. We show for the first time that pathological anoikis can be triggered by a process that requires functional assembly of the plasminogen activation system on the surface of VSMCs.
regulated in the vessel wall. The rarefaction of VSMCs and the associated decrease in protease inhibitors could play a central role in vascular pathologies involving proteolysis of the ECM (8, 10) . Expression of plasminogen activators (tissue-or urokinase-type plasminogen activator, respectively, t-PA or u-PA) is modulated at various stages of vascular pathologies (11) . Moreover, SMCs can bind exogenous t-PA and u-PA and potentiate their activity (12) . Several studies point to involvement of the plasminogen activation system in pathologies, such as abdominal aortic aneurysms in which disappearance of VSMCs has been observed (10, 13) . Disruption of the balance between plasminogen activators and their inhibitors could therefore be a trigger for the pericellular generation of plasmin and subsequent associated cellular events. We suggest that under pathological conditions, plasmin could induce detachment of VSMCs from their surrounding ECM, causing them to undergo anoikis. In the present study, using primary cultures, we investigated whether plasmin can induce anoikis in vitro and ex vivo in media isolated from rat aorta. We then tested the ability of vascular SMCs to convert plasminogen into plasmin by an endogenous activator system and subsequently to induce anoikis.
MATERIALS AND METHODS

Chemicals and reagents
D-valyl-L-phenylalanyl-L-lysine chloromethane (ValPheLysCH 2 Cl) and 1,5-Dansyl-Glu-GlyArg chloromethane (dGGACK) were from France Biochem (Meudon, France), the chromogenic substrate methylmalonylhydroxyprolylarginine p-nitroanilide (CBS0065) from Diagnostica Stago (Asnières, France), and the GM6001 (N-[2(R)-2-(hydroxamidocarbonylmethyl)-4-methylpentanoyl]-L-tryptophanemethylamide) from Calbiochem. α-2-antiplasmin was a generous gift from Dr. Lijnen, (Centrum voor transgene technologie en gen therapie, Belgium). Fibronectin was obtained from Invitrogen (Cergy Pontoise, France). Plasminogen was purified from fresh-frozen human plasma as described previously (14) . Plasmin was prepared by activation of plasminogen with immobilized u-PA (15) .
Cell culture and aorta isolation
Vascular smooth muscle cells (VSMCs) were isolated from Wistar rat abdominal aortas (16) . VSMCs were cultured in DMEM containing 10% fetal calf serum and used for experiments before the 4 th passage. Human VSMCs were isolated following the same protocol from radial arteries (surgical waste). Alternatively, adventitia-free aortas from the same source were cut into 2 mm rings, carefully washed with PBS, and placed in RPMI with or without various concentrations of plasmin.
Cell detachment assay
VSMCs were grown to confluence in 96-well plates and were serum-deprived for 24 h before stimulation. At the end of the experiment, the cells were washed with PBS. Remaining viable adherent cells were assessed by using the MTT test (3-[4,5-dimethylthiazol-2-yl]-2,5-diphenyltetrazolium bromide) (17) . Trypan blue exclusion test performed on trypsinized cells confirmed that 95% of remaining adherent cells did not exhibit membrane permeabilization.
Determination of nuclear morphology
VSMCs were grown on four-well slide chambers until confluence and serum-deprived for 24 h. After stimulation, the cells were fixed with cold methanol for 5 min, and stained by standard hematoxylin-eosin procedure before microscopic observation.
TUNEL assay
Terminal transferase dUTP Nick End Labeling (TUNEL) technique was used in situ to visualize DNA fragmentation, according to the manufacturer's instructions (Roche Molecular Biochemicals). Total nuclei number was determined after counterstaining with 100 ng/ml DAPI (4',6'-diamidino-2-phenylindole hydrochloride). Apoptotic index was calculated as the ratio of TUNEL-positive nuclei relative to total DAPI-stained nuclei (Mean count of three representative fields from two separate experiments containing ~200 cells for each condition).
DNA ladders
Genomic DNA was isolated from VSMCs by using standard DNA extraction methods (G-NOME kit, Bio101, Vista, CA). Adherent cells were scraped off into the culture medium and pooled with floating cells. DNA (10 µg) extracted according to the manufacturer's instruction, was separated by electrophoresis in a 1.8% agarose gel containing 0.5 µg/mL ethidium bromide.
Western blot analysis
Cells were washed twice with PBS, the pellet was then lysed in a buffer containing 1% Triton X-100 in PBS (15 min at 4°C), sonicated, and centrifuged at 10,000 g for 10 min at 4°C. Equal amounts of protein extracts were separated by a 10% SDS-PAGE. The gels were transblotted onto a nitrocellulose membrane, blocked with 5% milk powder in TBS-T (tris buffer saline, pH 7.4, 0.1% Tween 20) for 1 h and then incubated with either a polyclonal serum anti-rat fibronectin (Biogenesis, Poole, UK) at a 1:1000 dilution as suggested by the manufacturer, an anti-α-2 antiplasmin IgG (Biopool, Uppsala, Sweden) at 10 µg/mL or a monoclonal IgG (CPL15) anti-plasmin(ogen) at 1 µg/mL as described (18) . Membranes were then washed with TBS-T and incubated with appropriate secondary antibody conjugated to horseradish peroxidase (1:1500 for 1 h). After five washes, the signal was detected by using the chemiluminescence kit (Amersham, ECL kit, Arlington Heights, IL).
Determination of zymographic activities
Electrophoresis of samples prepared as described above was performed under non-reducing conditions in a 10% polyacrylamide gel containing or not 1 mg/mL gelatin. The gels were renatured as described previously (19) and incubated, respectively, in an appropriate buffer before staining with Coomassie blue, or carefully overlaid on a fibrin-agar gel (20) . Fibrin autography was followed at 37°C for 4 to 24 h and pictures of lysis area were taken on a dark background at regular intervals. The plasminogen activator was further identified in fibrin-agar gels containing 100 µg/mL of immunoglobulins directed against t-PA.
Plasminogen activation on VSMCs
VSMCs were grown to confluence in 96-well plates and deprived of serum 24 h before stimulation. The cells were then incubated with various inhibitors in presence or absence of plasminogen in a total volume of 100 µl/well. Plasmin generation was assessed by addition of 0.75 mM CBS0065 and by measuring the release of p-nitroaniline at A 405 /nm vs. time with a thermostated plate reader at 37°C (MR5000, Dynatech) (21) . Following activation, the plate was washed with PBS, and the amount of cell-bound plasmin was detected by adding 50 µl of chromogenic substrate as indicated above. Alternatively, cells incubated with plasminogen were centrifuged and plasmin was quantified in the cell-free conditioned medium by mixing an aliquot of 50 µl with an equal volume of CBS0065. This latter assay measures the plasmin generated and accumulated in the cell supernatant after 16 h of incubation. Plasmin concentration was calculated from rates of A 405 /minute according to Fleury et al. (22) .
Statistical analysis
Results are expressed as means ± SD unless otherwise stated. A one-factor ANOVA was performed followed by a Fisher test in order to evaluate the difference between each condition and the control (Statview software). Statistical significance was accepted for P<0.05.
RESULTS
Plasmin induces anoikis of VSMCs
Anoikis is characterized by apoptotic features in cells following their detachment from the surrounding ECM (23) . In situ TUNEL reaction provided evidence of DNA fragmentation in both adherent and floating plasmin-treated cells (Fig. 1A2 , A3, respectively) as compared with untreated control cells (Fig. 1A1) . After cyto-spinning the floating cells, hematoxylin/eosin (H/E) staining showed morphological changes such as nuclear condensation (black arrows) and fragmentation (white arrow) as well as membrane blebbing (circled, Fig. 1A4 ). VSMCs treated by 0.25 µM of plasmin for 16 h exhibited a DNA-ladder profile characteristic of apoptosis (Fig.  1B) as well as ~40% of cell detachment assessed using the MTT test (which quantifies the viable adherent cells remaining after plasmin stimulation) (Fig. 1C) .
TUNEL reaction performed on aortic segments treated ex vivo by 0.25 µM of plasmin for 16 h showed 40.5 ± 3% of positive nuclei versus 11 ± 2% in control, untreated aortas ( Fig. 1D4 vs. D2). The total number of nuclei was determined after DAPI counterstaining ( Fig. 1D1 and D3 ). Fibronectin fragmentation was assessed by Western blot performed on conditioned medium (Fig.  1E ). Plasmin induces fibronectin proteolysis both in the aorta (lane 2) and in vitro (lane 4) as shown by Western blot analysis of the corresponding conditioned medium, which displays bands representing cellular (240 kDa) and remnant plasma fibronectin (70 kDa) (24) fragments.
VSMCs convert plasminogen to plasmin
Cultured VSMCs can convert plasminogen into plasmin in a time-and dose-dependent manner ( Fig. 2A) . The generation of plasmin at the cell surface proceeds at a very low rate (Vmax=2.93 nmol/min.) due to the limited amount of t-PA expressed by SMCs in our cell culture system. However, the value for apparent Km (20.2 ± 1.3 nM) is within the range determined for t-PA bound to human VSMCs (12) and to a variety of other cells (25) . This is in contrast with previously reported values for t-PA in solution (Km = 65 µM), thus indicating that VSMCs stimulate plasminogen activation. Indeed, the cell extract but not the conditioned medium of VSMCs displays fibrinolytic activity corresponding to a free form of t-PA, as indicated by its electrophoretic migration (Fig. 2B top) and its inhibition in gels supplemented with 100 µg/mL of purified anti-t-PA IgG (Fig. 2B bottom) . Furthermore, the conversion of plasminogen into plasmin by VSMCs was selectively inhibited by a t-PA inhibitor (dGGACK) but not by amiloride, a u-PA inhibitor (Fig. 2C) . Both cell extract and supernatant exhibited activity corresponding most probably to t-PA/PAI-1 complexes suggesting that PAI-1 is present in excess in the supernatant. Altogether, these data indicate that in the cell system used in our experiments, constitutively expressed t-PA appears to be responsible for pericellular plasminogen activation and the subsequent generation of plasmin. Similar results were obtained by using human VSMCs in which conversion of plasminogen into plasmin was observed (data not shown).
Pericellular proteolysis of ECM
Plasmin generated from plasminogen by VSMCs induced cell retraction and detachment (Fig. 3  A) , and eventually cell death by anoikis (Fig. 3 A -inset) . Cell detachment was correlated with the accumulated amount of cell-bound plasmin (r=0.98). Plasmin was able to trigger cell retraction a few hours after stimulation whereas incubation with 0.5 µM plasminogen required at least 16 h before such changes could be observed. Similar results were obtained using human VSMCs (57±6% of detached cells after treatment by 1 µM of plasminogen for 24 h -data not shown). The pericellular generation of plasmin induced the degradation of ECM as shown in Fig.  3B , in which an accumulation of fibronectin fragments was detectable in the conditioned medium. This degradation is due to plasmin activity as it was prevented by ValPheLysCH 2 Cl, a peptide that blocks the catalytic site of plasmin (data not shown). We also observed the 66 kDa active form of matrix metalloproteinase 2 (MMP2) in the culture medium of cells incubated with increasing concentrations of plasminogen (Fig. 4C) . The use of GM 6001, an MMP inhibitor did not prevent fibronectin degradation (Fig. 3B) , cell retraction and detachment, nor did it modify plasmin generation in our cell culture system, at concentrations known to inhibit MMPs (26) (from 10 µM and up to 0.5 mM; data not shown). Inhibition of MMP-2 activity was verified by incubating gelatin zymography gels with 10 µM of GM 6001 (Fig. 3C, bottom) .
VSMC-mediated plasminogen activation: a pericellular process
The mechanism of plasminogen activation by VSMC-bound t-PA requires binding of plasminogen to the cell surface as indicated by the presence of active cell-bound plasmin (Fig.  4A, !) and by the prevention of plasminogen activation by VSMCs in the presence of ε-aminocaproic-acid (EACA, a competitor for plasminogen binding to the cell surface via its lysine binding sites) (Fig. 5A ). An IC 50 =0.9± 0.2 mM was calculated (concentration of EACA necessary for 50% inhibition of plasmin generation). As shown in Fig. 5B , EACA inhibited the formation of plasmin at the cell surface, most probably by prevention of plasminogen binding, leading to plasminogen accumulation in the supernatant. EACA was also able to prevent cell detachment in a dose-dependent manner to reach complete protection for a dose of 0.5 mM at 0.5 µM plasminogen. At this concentration, EACA also inhibited all the morphologic features characterizing anoikis (data not shown). Plasmin and plasminogen were detected by Western blot as a double band corresponding to their two glycosylated forms (Fig. 4B, ←, ⇐) (27) . Plasmin generated at the cell surface was also detected in the cell-conditioned medium (Fig. 4A, " , and 4B, ← top).
To further investigate the biological significance of plasmin generation by VSMCs, we tested the effects of α-2antiplasmin (α2AP), the main physiological inhibitor of plasmin. For this purpose, kinetics of plasmin generation from a saturating concentration of plasminogen (0.5 µM, Fig. 2A ) on VSMCs were monitored for 16 h in presence of increasing concentrations of α2AP (Fig. 6A) . Plasmin activity bound to the cell surface and released into the supernatant was also measured (Fig. 6A, inset) . α2AP caused a concentration dependent decrease in plasmin activity with an IC 50 = 64 nM. At a concentration of 31 nM, α2AP totally quenched the plasmin present in the supernatant (Fig. 6A , inset #,↓), but failed to prevent cell retraction and detachment (Fig. 6C, ↓) . Incubation with α2AP led to the formation of inactive plasmin/α2AP complexes detectable as a 140 kDa by Western blot (Fig. 6B) . No trace of such complexes could be detected at the cell surface (data not shown). These results indicate that plasmin released from the surface was immediately quenched by its specific inhibitor whereas cell-bound plasmin was still active (Fig.  6A, inset $) . Anoikis of VSMCs could thus be attributed to pericellular proteolysis induced by plasmin generated at the surface of the cells by t-PA constitutively expressed by SMCs.
DISCUSSION
In addition to its fibrinolytic activity, plasmin is able to cleave other substrates such as latent MMPs (28, 29) or adhesive glycoproteins, such as fibronectin, vitronectin or laminin (30) (31) (32) , that participate in cell anchorage and survival signaling via the integrin system. Using in vivo experimental models, it has been shown that plasmin generation is involved in pathological processes such as aneurysm formation and rupture (11, 33) and neuronal degeneration (34) which are, at least in part, characterized by a reduction in cellularity.
VSMCs produce their own ECM to which they adhere and are able to express t-PA and/or uPA that may generate pericellular plasmin (35) . Our hypothesis is that under pathological conditions, plasmin could be generated in situ at the surface of the cells and be responsible for inducing anoikis by degrading pericellular adhesive glycoproteins. In the present study, we show that plasmin is indeed able to induce detachment of VSMCs both in vitro and ex vivo, leading to morphological and biochemical changes characteristic of anoikis. Incubation of VSMCs with various concentrations of plasminogen induced a dose-dependent generation of plasmin at the surface of the cells, leading to VSMC anoikis. No addition of exogenous plasminogen activators was required to obtain these effects. The conversion of plasminogen into plasmin can be mediated by t-PA and u-PA, and prevented by plasminogen activator inhibitor (PAI-1) largely secreted by VSMCs in culture (36, 37). Expression of t-PA and u-PA by VSMCs depends upon various factors such as their phenotype, potential extracellular stimulation, or a pathological context such as atherosclerosis (35, (38) (39) (40) . Exogenous stimuli affect differently the expression of u-PA and t-PA (41) . The cell fraction of VSMCs that we used for our study exhibited tPA activity. The presence of t-PA/PAI-1 complexes and the absence of t-PA activity in the supernatant suggests that PAI-1 is secreted in excess as compared with t-PA. The excess of PAI-1 in the supernatant did not affect the activity of membrane-bound t-PA, confirming previously reported binding experiments (12) .
Activation of plasminogen at the cell surface and anoikis were also both inhibited by EACA, a competitor of plasminogen binding, suggesting that specific binding to cellular acceptors via carboxy-terminal lysine residues is necessary to convert plasminogen into plasmin. In our cell system, assembly of plasminogen and t-PA on the cell membrane is therefore required for the generation of plasmin in situ. Plasmin released in the conditioned medium could be trapped by addition of α 2 AP, the physiological circulating inhibitor of plasmin. At a concentration of 0.5 µM plasminogen, 31 nM α 2 AP completely inhibited the plasmin in the supernatant but failed to block cell-bound plasmin activity and cell anoikis, arguing for a cellular process. At higher concentrations of α 2 AP (>125 nM) a trend to a decrease in cell-bound plasmin activity and protection from anoikis were however observed. Since cell-bound plasmin is protected from inhibition by α 2 AP (42), these effects are most probably related to a reduced positive feedback for plasminogen binding, as has been described in a fibrin surface system (43, 44) .
The observation of anoikis in the absence of active plasmin in the supernatant adds further support to the concept of pericellular proteolysis as a surface-controlled process. Smooth muscle cells are dependent on survival signals coming from the ECM. By degrading ECM components, plasmin could lead to the disruption of survival signals and eventually trigger programmed cell death (45) . Fibronectin is implicated in cell survival through activation of the focal adhesion kinase signaling pathway, and could regulate expression of anti-apoptotic genes such as bcl-2 (46). Disruption of fibronectin/integrin signaling has been reported to be the cause of serumdeprived thyroid cell anoikis (47) , and serum starvation-induced apoptosis of SMCs was associated with cellular fibronectin degradation (48) . Soluble fibronectin peptides induce fibroblast apoptosis (49) and fibroblast survival requires interaction of integrins with the cell-(via RGD) and the heparin binding domain of fibronectin (50) . Intracellular signaling linking fibronectin degradation to anoikis is not the focus of the present work, and remains to be investigated in comparison with the well-explored intracellular pathways leading to spontaneous physiological anoikis (2) . We cannot exclude that plasmin could cleave cell-adhesion molecules as shown for E-Cadherin (51) or neural cell adhesion molecule L1, which undergoes cleavage in the middle of fibronectin-like domain after addition of plasminogen to neurons and melanoma cells (52) . Plasmin is a wide-spectrum protease also able to cleave and activate directly or indirectly the matrix metalloproteinases (11, 28) . Therefore, active MMPs could be the molecular effectors of plasmin-induced anoikis. In our model, we demonstrated that plasmin generated at the surface of the cell could in turn generate an active truncated form of MMP2, as detected by gelatin zymography. However, GM6001, a broad range inhibitor of MMPs, did not prevent plasmin-induced fibronectin fragmentation, cell detachment and anoikis of VSMCs, in agreement with a recent report (53) . This result suggests that plasmin might act as a pericellular proteolytic factor independently of the MMP activation system.
In conclusion, we provide evidence that constitutively expressed t-PA can generate plasmin at the surface of VSMCs in primary culture, at concentrations sufficient to induce pericellular proteolysis and subsequent anoikis. Pathological factors influencing expression of plasminogen activators by VSMCs, and conditions favoring the bio-availability of plasminogen as a pericellular substrate, remain to be further investigated. Such a cell-dependent phenomenon could be involved as an extracellular trigger capable of inducing cell disappearance in different vascular pathologies.
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